Molecular diagnostic tests for hereditary cancers allow an early detection of genetic mutations that increase the risk of developing specific tumors. This information can also be used by oncologist for prevention or to design specific treatments.
-
Marco Alessandro Pierotti
Head of CGT Lab & R&D Diagnostic and Scientific Director of BiLiGeCT project
Accredited by National Health Service in Italy
Our genetic testing facility is officially accredited by the Italian National Health Service (Servizio Sanitario Nazionale, SSN) and registered in the Regional Registry of Accredited Facilities at n.1118 on 31/08/2011 at the sub-branch of Cytogenetics and Medical Genetics for the performance of specialized laboratory Genetics and Molecular Biology.
-
Certifications and Quality controls
Certified laboratory UNI EN ISO 9001:2015 n. IT256850
Certified laboratory SIGUCERT n. 032
External quality control
EMQN 2021 | ISS 2020 EMQN 2020 | ISS 2019 EMQN 2019 | ISS 2018 VEQ 2021 VEQ 2019
-
Hospital affiliations
If you are a doctor or a healthcare professional and you would like to have access to our genetic testing services through your hospital, contact us.
Accredited
Accredited laboratory UNI EN ISO 15189:2013
Acknowledgments
Cogentech S.R.L. Società Benefit a Socio Unico soggetta all’attività di direzione e coordinamento di IFOM - Istituto Fondazione di Oncologia Molecolare ETS
Registered Office: via Adamello 16, 20139 Milan, Italy – Fully paid up share Capital 1.100.000 €
Local Unit: c/o Parco Scientifico e Tecnologico della Sicilia S.c.p.a. - Z.I. Blocco Palma I, Stradale V. Lancia, 57 - 95121 Catania
Tax Code, VAT and Milano, Monza, Brianza and Lodi Chamber of Commerce Register n. 04641450962 - R.E.A. MI-1763886
